Image Credits: Docwire News

Paris, France, Oct 15 (AFP/APP): A five-year-old girl with a rare neurodegenerative disease died in the US while taking part in a gene therapy trial run by French biotechnology company Lysogene, the firm said Thursday. The little girl was suffering from Sanfilippo syndrome or mucopolysaccharidosis type III, a rare genetic disease that alters brain development after birth and leads to premature death.

 

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Emirates to start Dubai-Tel Aviv daily flights

Dubai: It emerged on Thursday that Emirates will be starting daily flights…

Two-day pharma and healthcare expo kickstarts

Lahore: Pak Pharma and Healthcare expo in collaboration with the Pakistan Pharmaceutical…